Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beyeler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Dental-Revue (Solothurn, Switzerland)|November 1, 1985
[Principles for angle measurement on models]M Beyeler
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 25, 2003
[Standard and experimental therapy of cutaneous T-cell lymphoma]M Beyeler, R Dummer
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 7, 2004
[Cutaneous lymphoma]M Beyeler, G Burg, R Dummer
Praxis|October 7, 2003
[Cutaneous neoplasms]R Dummer, M Beyeler, J Morcinek, et al.
Calcified Tissue International|November 12, 2005
Compartmental bone morphometry in the mouse femur: reproducibility and resolution dependence of microtomographic measurementsT Kohler, M Beyeler, D Webster, et al.
Onkologie|September 7, 2004
The spectrum of mesenchymal skin neoplasms reflected by the new WHO classificationM Beyeler, W Kempf, J Hafner, et al.
Molecular & General Genetics : MGG|November 15, 1995
Structural genes for salicylate biosynthesis from chorismate in Pseudomonas aeruginosaL Serino, C Reimmann, H Baur, et al.
Journal of Bacteriology|January 1, 1997
Biosynthesis of pyochelin and dihydroaeruginoic acid requires the iron-regulated pchDCBA operon in Pseudomonas aeruginosaL Serino, C Reimmann, P Visca, et al.
Molecular Microbiology|April 1, 1997
The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipaseC Reimmann, M Beyeler, A Latifi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)K Spieth, R Kaufmann, R Dummer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Dental-Revue (Solothurn, Switzerland)|November 1, 1985
[Principles for angle measurement on models]M Beyeler
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|November 25, 2003
[Standard and experimental therapy of cutaneous T-cell lymphoma]M Beyeler, R Dummer
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 7, 2004
[Cutaneous lymphoma]M Beyeler, G Burg, R Dummer
Praxis|October 7, 2003
[Cutaneous neoplasms]R Dummer, M Beyeler, J Morcinek, et al.
Calcified Tissue International|November 12, 2005
Compartmental bone morphometry in the mouse femur: reproducibility and resolution dependence of microtomographic measurementsT Kohler, M Beyeler, D Webster, et al.
Onkologie|September 7, 2004
The spectrum of mesenchymal skin neoplasms reflected by the new WHO classificationM Beyeler, W Kempf, J Hafner, et al.
Molecular & General Genetics : MGG|November 15, 1995
Structural genes for salicylate biosynthesis from chorismate in Pseudomonas aeruginosaL Serino, C Reimmann, H Baur, et al.
Journal of Bacteriology|January 1, 1997
Biosynthesis of pyochelin and dihydroaeruginoic acid requires the iron-regulated pchDCBA operon in Pseudomonas aeruginosaL Serino, C Reimmann, P Visca, et al.
Molecular Microbiology|April 1, 1997
The global activator GacA of Pseudomonas aeruginosa PAO positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipaseC Reimmann, M Beyeler, A Latifi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 8, 2008
Temozolomide plus pegylated interferon alfa-2b as first-line treatment for stage IV melanoma: a multicenter phase II trial of the Dermatologic Cooperative Oncology Group (DeCOG)K Spieth, R Kaufmann, R Dummer, et al.
Pageof 2